7 Feb 2012 08:41
RNS Number : 9286W
e-Therapeutics plc
07 February 2012
Holdings in Company: e-Therapeutics plc
7 February 2012 e-Therapeutics plc (AIM: ETX) was notified on 6 February that, as of 3 February 2012, RAB Special Situations (Master) Fund Limited no longer has a beneficial holding exceeding 3% of the Company's issued ordinary shares.
Contacts:
e-Therapeutics plc
Daniel Elger
Tel: +44 (0) 7909 915 068
www.etherapeutics.co.uk
Panmure Gordon (UK) Limited
Andrew Burnett / Fred Walsh
Tel: +44 (0) 20 7459 3600
www.panmure.com
This information is provided by RNS
The company news service from the London Stock Exchange